Founded in 2000 and headquartered in Mount Laurel, N.J., ImpactRx%u2019s longitudinal panels of high value, iPhone-connected physicians is the exclusive source of continuously captured promotion and treatment data. Through its proprietary methodology, the Company annually captures one million details and three-million treatment decisions, fueling its unique ImpactData%u2122 industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers. Visit ImpactRx at www.impactrx.com.
ImpactRx, the pioneer in measuring the impact of promotion on physicians' attitudes and prescribing behavior, announced today the launch of a voice capture response enhancement to their unique POP 2.0™ research tool.
ImpactRx, a Symphony Technology Group (STG) company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies, in order to combine the highly complementary capabilities of the two companies.
ImpactRx measures the impact of promotion on physician prescribing behavior. Patients request more than 250,000 brand annually, ImpactRx then records physician's treatment behavior in response to their request.
ImpactRx expanded its psychiatry research panel to better serve the growing neruoscience category, in particular ADD/ADHD market. Psychiatrists are evaluating and reporting prescribing behavior. iPhone-connected psychiatrists capture feedback in real time.